Abeona Therapeutics Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-10.1% vs price
Base Case (Median)
140.9% vs price
Bull Case (75th pct.)
146.1% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-3.76 | -161.1% | High (40%) |
| EV/EBITDA | $14.84 | 140.9% | Medium (20%) |
| Earnings Power Value | $15.49 | 151.4% | Medium (50%) |
Based on 3 out of 8 methods, ABEO appears fairly valued at the current price of $6.16. The base case fair value of $14.84 implies 140.9% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.